Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in Hong Kong
1 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleSwitching of Sildenafil to Riociguat in CTEPH Patients
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 30
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06715280